It was shown that RBP7 is significantly downregulated in hormone receptor-positive (HR+) breast cancer tissues compared to normal tissues, and its low expression correlates with poor overall survival (OS) and higher tumor T-stage and Ki67 score [90]. Here, RBP7 is linked to neoplasm.